Histone onco-modifications

Post-translational modification of histones provides an important regulatory platform for processes such as gene expression, DNA replication and repair, chromosome condensation and segregation and apoptosis. Disruption of these processes has been linked to the multistep process of carcinogenesis. We review the aberrant covalent histone modifications observed in cancer, and discuss how these epigenetic changes, caused by alterations in histone-modifying enzymes, can contribute to the development of a variety of human cancers. As a conclusion, a new terminology ‘histone onco-modifications’ is proposed to describe post-translational modifications of histones, which have been linked to cancer. This new term would take into account the active contribution and importance of these histone modifications in the development and progression of cancer.

[1]  S. Jackson,et al.  Screen for DNA-damage-responsive histone modifications identifies H 3 K 9 Ac and H 3 K 56 Ac in human cells , 2009 .

[2]  D. Gilbert,et al.  Heterochromatin and tri-methylated lysine 20 of histone H4 in animals , 2004, Journal of Cell Science.

[3]  Matteo Pellegrini,et al.  Epigenetic Reprogramming by Adenovirus e1a , 2008, Science.

[4]  O. Kovalchuk,et al.  Loss of DNA methylation and histone H4 lysine 20 trimethylation in human breast cancer cells is associated with aberrant expression of DNA methyltransferase 1, Suv4-20h2 histone methyltransferase and methyl-binding proteins , 2006, Cancer biology & therapy.

[5]  N. Sheibani,et al.  Regulation of Angiogenesis by Histone Chaperone HIRA-mediated Incorporation of Lysine 56-acetylated Histone H3.3 at Chromatin Domains of Endothelial Genes* , 2010, The Journal of Biological Chemistry.

[6]  M. Fraga,et al.  Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer , 2005, Nature Genetics.

[7]  P. Lichter,et al.  hMOF Histone Acetyltransferase Is Required for Histone H4 Lysine 16 Acetylation in Mammalian Cells , 2005, Molecular and Cellular Biology.

[8]  Y. Zeng,et al.  EZH2 supports ovarian carcinoma cell invasion and/or metastasis via regulation of TGF-beta1 and is a predictor of outcome in ovarian carcinoma patients. , 2010, Carcinogenesis.

[9]  Thomas A. Milne,et al.  Physical Association and Coordinate Function of the H3 K4 Methyltransferase MLL1 and the H4 K16 Acetyltransferase MOF , 2005, Cell.

[10]  Jianfeng Guo,et al.  EZH2 regulates expression of p57 and contributes to progression of ovarian cancer in vitro and in vivo , 2011, Cancer science.

[11]  R. Versteeg,et al.  Lysine-specific demethylase 1 is strongly expressed in poorly differentiated neuroblastoma: implications for therapy. , 2009, Cancer research.

[12]  Yipeng Wang,et al.  Profiling of histone H3 lysine 9 trimethylation levels predicts transcription factor activity and survival in acute myeloid leukemia. , 2010, Blood.

[13]  S. Meier-Ewert,et al.  A Novel Gene (PLU-1) Containing Highly Conserved Putative DNA/Chromatin Binding Motifs Is Specifically Up-regulated in Breast Cancer* , 1999, The Journal of Biological Chemistry.

[14]  Juri Rappsilber,et al.  The putative oncogene GASC1 demethylates tri- and dimethylated lysine 9 on histone H3 , 2006, Nature.

[15]  T. Liang,et al.  Overexpression of myocyte enhancer factor 2 and histone hyperacetylation in hepatocellular carcinoma , 2007, Journal of Cancer Research and Clinical Oncology.

[16]  O. Kovalchuk,et al.  Estrogen-Induced Rat Breast Carcinogenesis is Characterized by Alterations in DNA Methylation, Histone Modifications, and Aberrant microRNA Expression , 2007, Cell cycle.

[17]  S. Richard,et al.  Thrombospondin-1 Is a Transcriptional Repression Target of PRMT6* , 2009, The Journal of Biological Chemistry.

[18]  L. Poirier,et al.  Histone H3 lysine 9 and H4 lysine 20 trimethylation and the expression of Suv4-20h2 and Suv-39h1 histone methyltransferases in hepatocarcinogenesis induced by methyl deficiency in rats. , 2006, Carcinogenesis.

[19]  Robert L Moritz,et al.  PRMT5-mediated methylation of histone H4R3 recruits DNMT3A, coupling histone and DNA methylation in gene silencing , 2009, Nature Structural &Molecular Biology.

[20]  K. Helin,et al.  A model for transmission of the H3K27me3 epigenetic mark , 2008, Nature Cell Biology.

[21]  J. Issa,et al.  Downregulation of Histone H3 Lysine 9 Methyltransferase G9a Induces Centrosome Disruption and Chromosome Instability in Cancer Cells , 2008, PloS one.

[22]  Osama Sharaf,et al.  Epigenetic events, remodelling enzymes and their relationship to chromatin organization in prostatic intraepithelial neoplasia and prostatic adenocarcinoma , 2007, BJU international.

[23]  Yusuke Nakamura,et al.  Enhanced SMYD3 expression is essential for the growth of breast cancer cells , 2006, Cancer science.

[24]  Claude Sardet,et al.  Jcb: Article , 2022 .

[25]  J. Herman,et al.  Histone modifications and silencing prior to DNA methylation of a tumor suppressor gene. , 2003, Cancer cell.

[26]  K. Robertson.  DNA methylation and human disease , 2005, Nature Reviews Genetics.

[27]  Yang Shi,et al.  Histone Demethylation Mediated by the Nuclear Amine Oxidase Homolog LSD1 , 2004, Cell.

[28]  Hideaki Kato,et al.  Alterations of DNA methylation and histone modifications contribute to gene silencing in hepatocellular carcinomas , 2007, Hepatology research : the official journal of the Japan Society of Hepatology.

[29]  Manel Esteller,et al.  Role of the RB1 family in stabilizing histone methylation at constitutive heterochromatin , 2005, Nature Cell Biology.

[30]  S. Baylin,et al.  Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction? , 2006, Nature Reviews Cancer.

[31]  Satyajeet P. Khare,et al.  Overexpression of histone variant H2A.1 and cellular transformation are related in N-nitrosodiethylamine-induced sequential hepatocarcinogenesis , 2011, Experimental biology and medicine.

[32]  S. Galande,et al.  p300-mediated Acetylation of Histone H3 Lysine 56 Functions in DNA Damage Response in Mammals , 2010, The Journal of Biological Chemistry.

[33]  S. Horvath,et al.  Cellular histone modification patterns predict prognosis and treatment response in resectable pancreatic adenocarcinoma: results from RTOG 9704. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  Z. Herceg,et al.  Epigenetic interplay between histone modifications and DNA methylation in gene silencing. , 2008, Mutation research.

[35]  A. Aszódi,et al.  H3K27me3 forms BLOCs over silent genes and intergenic regions and specifies a histone banding pattern on a mouse autosomal chromosome. , 2009, Genome research.

[36]  J. Lucchesi,et al.  A new human member of the MYST family of histone acetyl transferases with high sequence similarity to Drosophila MOF. , 2000, Biochimica et biophysica acta.

[37]  A. Feinberg,et al.  Hypomethylation distinguishes genes of some human cancers from their normal counterparts , 1983, Nature.

[38]  C. Allis,et al.  Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark. , 2007, Molecular cell.

[39]  T. Mikkelsen,et al.  Genome-wide maps of chromatin state in pluripotent and lineage-committed cells , 2007, Nature.

[40]  T. Richmond,et al.  Crystal structure of the nucleosome core particle at 2.8 Å resolution , 1997, Nature.

[41]  Edward L. Lee,et al.  Global Histone H4 Acetylation and HDAC2 Expression in Colon Adenoma and Carcinoma , 2009, Digestive Diseases and Sciences.

[42]  K. Jang,et al.  Expression of DBC1 and SIRT1 Is Associated with Poor Prognosis of Gastric Carcinoma , 2009, Clinical Cancer Research.

[43]  S. Dhanasekaran,et al.  The polycomb group protein EZH2 is involved in progression of prostate cancer , 2002, Nature.

[44]  C. Marras,et al.  Enhancer of Zeste 2 (EZH2) is up‐regulated in malignant gliomas and in glioma stem‐like cells , 2011, Neuropathology and applied neurobiology.

[45]  S. Horvath,et al.  Global histone modification patterns predict risk of prostate cancer recurrence , 2005, Nature.

[46]  S. Baylin,et al.  Tumor Suppressor HIC1 Directly Regulates SIRT1 to Modulate p53-Dependent DNA-Damage Responses , 2005, Cell.

[47]  H. Cedar,et al.  Linking DNA methylation and histone modification: patterns and paradigms , 2009, Nature Reviews Genetics.

[48]  K. Jang,et al.  SIRT1 Expression is Associated With Poor Prognosis of Diffuse Large B-Cell Lymphoma , 2008, The American journal of surgical pathology.

[49]  M. Pazin,et al.  Histone H4-K16 Acetylation Controls Chromatin Structure and Protein Interactions , 2006, Science.

[50]  Yusuke Nakamura,et al.  SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells , 2004, Nature Cell Biology.

[51]  E. Brambilla,et al.  Loss of Histone H4K20 Trimethylation Occurs in Preneoplasia and Influences Prognosis of Non–Small Cell Lung Cancer , 2008, Clinical Cancer Research.

[52]  Renato Paro,et al.  Distinct contributions of histone H3 lysine 9 and 27 methylation to locus-specific stability of polycomb complexes. , 2004, Molecular cell.

[53]  Michael Grunstein,et al.  Global histone acetylation and deacetylation in yeast , 2000, Nature.

[54]  Peter A. Jones,et al.  Epigenetics in cancer. , 2010, Carcinogenesis.

[55]  D. Reinberg,et al.  TILRR, a Novel IL-1RI Co-receptor, Potentiates MyD88 Recruitment to Control Ras-dependent Amplification of NF-κB* , 2009, The Journal of Biological Chemistry.

[56]  B. Joseph,et al.  Cracking the death code: apoptosis-related histone modifications , 2010, Cell Death and Differentiation.

[57]  Mengzhong Liu,et al.  Prognostic impact of H3K27me3 expression on locoregional progression after chemoradiotherapy in esophageal squamous cell carcinoma , 2009, BMC Cancer.

[58]  G. Calin,et al.  Regulation of tumor angiogenesis by EZH2. , 2010, Cancer cell.

[59]  O. Hermanson,et al.  Opposing effects of hMOF and SIRT1 on H4K16 acetylation and the sensitivity to the topoisomerase II inhibitor etoposide , 2010, Oncogene.

[60]  R. Kornberg,et al.  Twenty-Five Years of the Nucleosome, Fundamental Particle of the Eukaryote Chromosome , 1999, Cell.

[61]  S. Horvath,et al.  Global levels of histone modifications predict prognosis in different cancers. , 2009, The American journal of pathology.

[62]  K. Hata,et al.  Histone methylation is mechanistically linked to DNA methylation at imprinting control regions in mammals. , 2009, Human molecular genetics.

[63]  Paul Tempst,et al.  PLU-1 is an H3K4 demethylase involved in transcriptional repression and breast cancer cell proliferation. , 2007, Molecular cell.

[64]  A. Shiras,et al.  Epigenetic regulation of DNA methyltransferases: DNMT1 and DNMT3B in gliomas , 2011, Journal of Neuro-Oncology.

[65]  J. Bender,et al.  H3 Lysine 9 Methylation Is Maintained on a Transcribed Inverted Repeat by Combined Action of SUVH6 and SUVH4 Methyltransferases , 2005, Molecular and Cellular Biology.

[66]  H. Kimura,et al.  G9a/GLP complexes independently mediate H3K9 and DNA methylation to silence transcription , 2008, The EMBO journal.

[67]  Guo-Cheng Yuan,et al.  EZH1 mediates methylation on histone H3 lysine 27 and complements EZH2 in maintaining stem cell identity and executing pluripotency. , 2008, Molecular cell.

[68]  S. Jang,et al.  The Global Histone Modification Pattern Correlates with Cancer Recurrence and Overall Survival in Gastric Adenocarcinoma , 2008, Annals of Surgical Oncology.

[69]  Qiang Yu,et al.  Polycomb protein EZH2 regulates E2F1-dependent apoptosis through epigenetically modulating Bim expression , 2010, Cell Death and Differentiation.

[70]  R. Büttner,et al.  Prognostic relevance of global histone H3 lysine 4 (H3K4) methylation in renal cell carcinoma , 2010, International journal of cancer.

[71]  K. Helin,et al.  The H3K27me3 demethylase, KDM6B, is induced by Epstein–Barr virus and over-expressed in Hodgkin's Lymphoma , 2011, Oncogene.

[72]  Debashis Ghosh,et al.  EZH2 is a marker of aggressive breast cancer and promotes neoplastic transformation of breast epithelial cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[73]  Tao Xi,et al.  Effects of SMYD3 over-expression on cell cycle acceleration and cell proliferation in MDA-MB-231 human breast cancer cells , 2011, Medical oncology.

[74]  S. Jackson,et al.  Human HDAC1 and HDAC2 function in the DNA-damage response to promote DNA nonhomologous end-joining , 2010, Nature Structural &Molecular Biology.

[75]  Scott A. Armstrong,et al.  MLL translocations, histone modifications and leukaemia stem-cell development , 2007, Nature Reviews Cancer.

[76]  Kristian Helin,et al.  The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells. , 2007, Genes & development.

[77]  Gordon B Mills,et al.  Loss of trimethylation at lysine 27 of histone H3 is a predictor of poor outcome in breast, ovarian, and pancreatic cancers , 2008, Molecular carcinogenesis.

[78]  Byoung Kil Lee,et al.  Expression of DBC1 and SIRT1 is associated with poor prognosis for breast carcinoma. , 2011, Human pathology.

[79]  C. Allis,et al.  DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA , 2007, Nature.

[80]  S. Khorasanizadeh.  The Nucleosome From Genomic Organization to Genomic Regulation , 2004, Cell.

[81]  Hong Lin,et al.  Global Histone Modification Patterns as Prognostic Markers to Classify Glioma Patients , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[82]  Peter A. Jones,et al.  Histone H3-lysine 9 methylation is associated with aberrant gene silencing in cancer cells and is rapidly reversed by 5-aza-2'-deoxycytidine. , 2002, Cancer research.

[83]  Y. Kubo,et al.  Strong expression of a longevity-related protein, SIRT1, in Bowen’s disease , 2007, Archives of Dermatological Research.

[84]  M. J. van de Vijver,et al.  Genomic amplification and oncogenic properties of the GASC1 histone demethylase gene in breast cancer , 2009, Oncogene.

[85]  P. Schirmacher,et al.  Enhancer of zeste homolog 2 (EZH2) expression is an independent prognostic factor in renal cell carcinoma , 2010, BMC Cancer.

[86]  K. Helin,et al.  The H3K27me3 demethylase JMJD3 contributes to the activation of the INK4A-ARF locus in response to oncogene- and stress-induced senescence. , 2009, Genes & development.

[87]  Richard Pazdur,et al.  FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma. , 2007, The oncologist.

[88]  Todd D. Westergard,et al.  Phosphorylation of MLL by ATR is Required for Execution of Mammalian S Phase Checkpoint , 2010, Nature.

[89]  S. Orkin,et al.  Supplemental Data EZH 1 Mediates Methylation on Histone H 3 Lysine 27 and Complements EZH 2 in Maintaining Stem Cell Identity and Executing Pluripotency , 2008 .

[90]  Y. Ping,et al.  The Expression of H3K9Ac, H3K14Ac, and H4K20TriMe in Epithelial Ovarian Tumors and the Clinical Significance , 2007, International Journal of Gynecologic Cancer.

[91]  R. Kingston,et al.  Chromatin Compaction by a Polycomb Group Protein Complex , 2004, Science.

[92]  Dustin E. Schones,et al.  High-Resolution Profiling of Histone Methylations in the Human Genome , 2007, Cell.

[93]  Kirk C. Hansen,et al.  CBP / p300-mediated acetylation of histone H3 on lysine 56 , 2009, Nature.

[94]  O. Hermanson,et al.  Combinatorial action of the HDAC inhibitor trichostatin A and etoposide induces caspase-mediated AIF-dependent apoptotic cell death in non-small cell lung carcinoma cells , 2008, Oncogene.

[95]  M. Grunstein,et al.  Transcriptional repression by UME6 involves deacetylation of lysine 5 of histone H4 by RPD3 , 1998, Nature.

[96]  C. Allis,et al.  The language of covalent histone modifications , 2000, Nature.

[97]  Paul Greengard,et al.  Essential Role of the Histone Methyltransferase G9a in Cocaine-Induced Plasticity , 2010, Science.

[98]  Danny Reinberg,et al.  A silencing pathway to induce H3-K9 and H4-K20 trimethylation at constitutive heterochromatin. , 2004, Genes & development.

[99]  Dinshaw J. Patel,et al.  Haematopoietic malignancies caused by dysregulation of a chromatin-binding PHD finger , 2009, Nature.

[100]  P. Vertino,et al.  Role of hMOF-dependent histone H4 lysine 16 acetylation in the maintenance of TMS1/ASC gene activity. , 2008, Cancer research.

[101]  C. Peterson,et al.  Switching on Chromatin: Mechanistic Role of Histone H4-K16 Acetylation , 2006, Cell cycle.

[102]  David Hawke,et al.  A role for cell-cycle-regulated histone H3 lysine 56 acetylation in the DNA damage response , 2005, Nature.

[103]  F. Robert,et al.  Genome-wide replication-independent histone H3 exchange occurs predominantly at promoters and implicates H3 K56 acetylation and Asf1. , 2007, Molecular cell.

[104]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[105]  Michael Grunstein,et al.  Adenovirus Small e1a Alters Global Patterns of Histone Modification , 2008, Science.

[106]  B M Turner,et al.  Histone acetylation and an epigenetic code. , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.

[107]  Daniele Soria,et al.  Global histone modifications in breast cancer correlate with tumor phenotypes, prognostic factors, and patient outcome. , 2009, Cancer research.

[108]  E. Avvedimento,et al.  LSD1-mediated demethylation of histone H3 lysine 4 triggers Myc-induced transcription , 2010, Oncogene.

[109]  Wolfgang Fischle,et al.  Binary switches and modification cassettes in histone biology and beyond , 2003, Nature.

[110]  D. Ghosh,et al.  A polycomb repression signature in metastatic prostate cancer predicts cancer outcome. , 2007, Cancer research.

[111]  C. Allis,et al.  Translating the Histone Code , 2001, Science.

[112]  V. P. Collins,et al.  Differential expression of selected histone modifier genes in human solid cancers , 2006, BMC Genomics.

[113]  J. Côté,et al.  The MYST family of histone acetyltransferases. , 2003, Current topics in microbiology and immunology.

[114]  G. Giaccone,et al.  Global histone modifications predict prognosis of resected non small-cell lung cancer. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[115]  Cheng-Ping Yu,et al.  Prognostic significance of global histone modifications in resected squamous cell carcinoma of the esophagus , 2009, Modern Pathology.

[116]  A. Shilatifard,et al.  An operational definition of epigenetics. , 2009, Genes & development.

[117]  Y. Jeng,et al.  H3K9 histone methyltransferase G9a promotes lung cancer invasion and metastasis by silencing the cell adhesion molecule Ep-CAM. , 2012, Cancer research.

[118]  B. Ponder,et al.  Overexpression of LSD1 contributes to human carcinogenesis through chromatin regulation in various cancers , 2011, International journal of cancer.

[119]  James A. Cuff,et al.  A Bivalent Chromatin Structure Marks Key Developmental Genes in Embryonic Stem Cells , 2006, Cell.

[120]  Yi Zhang,et al.  New Nomenclature for Chromatin-Modifying Enzymes , 2007, Cell.

[121]  Zhiguo Zhang,et al.  Histone H3-K56 acetylation is important for genomic stability in mammals , 2009, Cell cycle.

[122]  Paul Tempst,et al.  PR-Set7 is a nucleosome-specific methyltransferase that modifies lysine 20 of histone H4 and is associated with silent chromatin. , 2002, Molecular cell.

[123]  M. Grunstein,et al.  Acetylation in Histone H3 Globular Domain Regulates Gene Expression in Yeast , 2005, Cell.

[124]  Yi Zhang,et al.  Regulation of histone methylation by demethylimination and demethylation , 2007, Nature Reviews Molecular Cell Biology.

[125]  T. Bagnyukova,et al.  Genetic and epigenetic changes in rat preneoplastic liver tissue induced by 2-acetylaminofluorene. , 2008, Carcinogenesis.

[126]  T. Kouzarides.  Chromatin Modifications and Their Function , 2007, Cell.

[127]  Y. Song,et al.  Derepression of CLDN3 and CLDN4 during ovarian tumorigenesis is associated with loss of repressive histone modifications , 2010, Carcinogenesis.

[128]  J. Licht,et al.  Deregulation of H3K27 methylation in cancer , 2010, Nature Genetics.

[129]  B. Turner,et al.  Defining an epigenetic code , 2007, Nature Cell Biology.

[130]  Jef D Boeke,et al.  Regulated nucleosome mobility and the histone code , 2004, Nature Structural &Molecular Biology.

[131]  François Fuks,et al.  DNA methylation and histone modifications: teaming up to silence genes. , 2005, Current opinion in genetics & development.

[132]  E. Ballestar,et al.  Allele‐specific histone lysine methylation marks regulatory regions at imprinted mouse genes , 2002, The EMBO journal.

[133]  B. Garcia,et al.  The histone variant macroH2A suppresses melanoma progression through regulation of CDK8 , 2010, Nature.

[134]  J. Cidlowski,et al.  Reciprocal Epigenetic Modification of Histone H2B occurs in Chromatin during Apoptosis in vitro and in vivo , 2009, Cell Death and Differentiation.

[135]  Peter Lichter,et al.  The histone acetyltransferase hMOF is frequently downregulated in primary breast carcinoma and medulloblastoma and constitutes a biomarker for clinical outcome in medulloblastoma , 2008, International journal of cancer.

[136]  C. Chen,et al.  JMJD3 is a histone H3K27 demethylase , 2007, Cell Research.

[137]  T. Nagy,et al.  SIRT1 is significantly elevated in mouse and human prostate cancer. , 2007, Cancer research.

[138]  S. Kurdistani.  Histone modifications in cancer biology and prognosis. , 2011, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques.

[139]  P. Pan,et al.  MOF and H4 K16 Acetylation Play Important Roles in DNA Damage Repair by Modulating Recruitment of DNA Damage Repair Protein Mdc1 , 2010, Molecular and Cellular Biology.

[140]  Bin Tean Teh,et al.  Somatic mutations of the histone H3K27 demethylase, UTX, in human cancer , 2009, Nature Genetics.

[141]  K. Helin,et al.  The histone methyltransferase SET8 is required for S-phase progression , 2007, The Journal of cell biology.

[142]  I. Rusyn,et al.  Methyl deficiency, alterations in global histone modifications, and carcinogenesis. , 2007, The Journal of nutrition.